Series B Boosts British Biotech’s Cell Therapy Automation With €22.6M
A solution to reduce the costs of cell therapy manufacturing is lab automation. Synthace’s software is designed to mesh together separate stages of the …
Powered by WPeMatico
Powered by WPeMatico